{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:17:41Z","timestamp":1773717461160,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["ONWebDUALS project, JNPD 01ED1511B"],"award-info":[{"award-number":["ONWebDUALS project, JNPD 01ED1511B"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00415-020-09799-z","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:11:24Z","timestamp":1586293884000},"page":"2130-2141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group"],"prefix":"10.1007","volume":"267","author":[{"given":"Kristin","family":"Diekmann","sequence":"first","affiliation":[]},{"given":"Magdalena","family":"Kuzma-Kozakiewicz","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Piotrkiewicz","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Gromicho","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Grosskreutz","sequence":"additional","affiliation":[]},{"given":"Peter M.","family":"Andersen","sequence":"additional","affiliation":[]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[]},{"given":"Hilmi","family":"Uysal","sequence":"additional","affiliation":[]},{"given":"Alma","family":"Osmanovic","sequence":"additional","affiliation":[]},{"given":"Olivia","family":"Schreiber-Katz","sequence":"additional","affiliation":[]},{"given":"Susanne","family":"Petri","sequence":"additional","affiliation":[]},{"given":"Sonja","family":"K\u00f6rner","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"9799_CR1","first-page":"99","volume":"155","author":"V Silani","year":"2017","unstructured":"Silani V, Ludolph A, Fornai F (2017) The emerging picture of ALS: A multisystem, not only a \u201cmotor neuron disease\u201d. Arch Ital Biol 155:99\u2013109","journal-title":"Arch Ital Biol"},{"key":"9799_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","volume":"80","author":"V Gallo","year":"2013","unstructured":"Gallo V, Wark PA, Jenab M et al (2013) Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort. Neurology 80:829\u2013838","journal-title":"Neurology"},{"key":"9799_CR3","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly \u00c9J, Wang H, Weisskopf MG et al (2013) Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:205\u2013211. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23134505","DOI":"10.3109\/21678421.2012.735240"},{"key":"9799_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J, K\u00fchnlein P, Hendrich C, Kassubek J, Sperfeld AD (2011) Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613\u2013617","journal-title":"J Neurol"},{"issue":"13","key":"9799_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A et al (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis symbol. Neurology 70(13):1004\u20131009","journal-title":"Neurology"},{"key":"9799_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/ene.12015","volume":"20","author":"S K\u00f6rner","year":"2013","unstructured":"K\u00f6rner S, Kollewe K, Ilsemann J et al (2013) (2013) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol 20:647\u2013654","journal-title":"Eur J Neurol"},{"key":"9799_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/21678421.2017.1336560","volume":"18","author":"C Moglia","year":"2017","unstructured":"Moglia C, Calvo A, Canosa A et al (2017) Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotroph Lateral Scler Front Degener 18:590\u2013597","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"9799_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jnnp-2011-301161","volume":"83","author":"MR Turner","year":"2012","unstructured":"Turner MR, Wotton C, Talbot K, Goldacre MJ (2012) Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: Indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 83:395\u2013398","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9799_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/21678421.2016.1154575","volume":"17","author":"CA Harwood","year":"2016","unstructured":"Harwood CA, Westgate K, Gunstone S et al (2016) Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Front Degener 17:377\u2013384","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"9799_CR10","doi-asserted-by":"crossref","unstructured":"Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G (1998) Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 55:201\u2013206. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9482362","DOI":"10.1001\/archneur.55.2.201"},{"key":"9799_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.clnu.2009.06.002","volume":"28","author":"BP Patel","year":"2009","unstructured":"Patel BP, Hamadeh MJ (2009) Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin. Nutr 28:604\u2013617","journal-title":"Clin. Nutr"},{"key":"9799_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.brainres.2009.11.051","volume":"1313","author":"I Carreras","year":"2010","unstructured":"Carreras I, Yuruker S, Aytan N et al (2010) Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res 1313:192\u2013201","journal-title":"Brain Res"},{"key":"9799_CR13","doi-asserted-by":"crossref","unstructured":"Prell T, Gaur N, Stubendorff B, R\u00f6diger A, Witte OW, Grosskreutz J (2019) Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. J Neurol Sci 397:92\u201395. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30597420","DOI":"10.1016\/j.jns.2018.12.035"},{"key":"9799_CR14","first-page":"205","volume":"10","author":"S Korner","year":"2019","unstructured":"Korner S, Kammeyer J, Zapf A et al (2019) Influence of environment and lifestyle on incidence and progress of amyotrophic lateral sclerosis in A German ALS population. Aging Dis Int Soc Aging Dis 10:205\u2013216","journal-title":"Aging Dis Int Soc Aging Dis"},{"key":"9799_CR15","doi-asserted-by":"crossref","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1\u20132):3\u201321","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"9799_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2016.00047","volume":"7","author":"SK Hollinger","year":"2016","unstructured":"Hollinger SK, Okosun IS, Mitchell CS (2016) Antecedent disease and amyotrophic lateral sclerosis: What is protecting whom? Front Neurol 7:47","journal-title":"Front Neurol"},{"key":"9799_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/17482960903384283","volume":"11","author":"E Beghi","year":"2010","unstructured":"Beghi E, Logroscino G, Chi\u00f2 A et al (2010) Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler 11:289\u2013292","journal-title":"Amyotroph Lateral Scler"},{"key":"9799_CR18","doi-asserted-by":"crossref","unstructured":"Pupillo E, Messina P, Giussani G et al (2014) Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol 75:708\u2013716. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24706338.","DOI":"10.1002\/ana.24150"},{"key":"9799_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2466\/pms.104.4.1251-1254","volume":"104","author":"EL Abel","year":"2007","unstructured":"Abel EL (2007) Football increases the risk for Lou Gehrig\u2019s disease, amyotrophic lateral sclerosis. Percept Mot Skills 104:1251\u20131254","journal-title":"Percept Mot Skills"},{"key":"9799_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/brain\/awh373","volume":"128","author":"A Chi\u00f2","year":"2005","unstructured":"Chi\u00f2 A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472\u2013476","journal-title":"Brain"},{"key":"9799_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/jnnp-2012-304724","volume":"84","author":"MHB Huisman","year":"2013","unstructured":"Huisman MHB, Seelen M, De Jong SW et al (2013) Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84:976\u2013981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9799_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/jnnp.2010.218982","volume":"83","author":"P Mattsson","year":"2012","unstructured":"Mattsson P, L\u00f6nnstedt I, Nygren I, Askmark H (2012) Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry 83:390\u2013394","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9799_CR23","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00415-014-7445-1","volume":"261","author":"M Seelen","year":"2014","unstructured":"Seelen M, van Doormaal PTC, Visser AE et al (2014) Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol 261:1949\u20131956","journal-title":"J Neurol"},{"key":"9799_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","volume":"82","author":"NA Sutedja","year":"2011","unstructured":"Sutedja NA, Van Der Schouw YT, Fischer K et al (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:638\u2013642","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9799_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","volume":"53","author":"JC Desport","year":"1999","unstructured":"Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53:1059\u20131063","journal-title":"Neurology"},{"key":"9799_CR26","doi-asserted-by":"crossref","unstructured":"Jawaid A, Murthy SB, Wilson AM et al (2010) A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler 11:542\u2013548. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20500116","DOI":"10.3109\/17482968.2010.482592"},{"key":"9799_CR27","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Ren\u00e9 F, Gonzalez De Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101:11159\u201311164","journal-title":"Proc Natl Acad Sci USA"},{"key":"9799_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","volume":"8","author":"E Dardiotis","year":"2018","unstructured":"Dardiotis E, Siokas V, Sokratous M et al (2018) Body mass index and survival from amyotrophic lateral sclerosis. Neurol Clin Pract 8:437\u2013444","journal-title":"Neurol Clin Pract"},{"key":"9799_CR29","doi-asserted-by":"crossref","unstructured":"Moura MC, Novaes MRCG, Eduardo EJ, Zago YSSP, Freitas RDNB, Casulari LA (2015) Prognostic factors in amyotrophic lateral sclerosis: a population-based study. PLoS One 10:e0141500. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26517122","DOI":"10.1371\/journal.pone.0141500"},{"key":"9799_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1179\/1743132812Y.0000000049","volume":"34","author":"SIK Dedic","year":"2012","unstructured":"Dedic SIK, Stevic Z, Dedic V, Stojanovic VR, Milicev M, Lavrnic D (2012) Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis? Neurol Res 34:576\u2013580","journal-title":"Neurol Res"},{"key":"9799_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75\u201382","journal-title":"Lancet Neurol"},{"key":"9799_CR32","doi-asserted-by":"crossref","unstructured":"Bouteloup C, Desport J-C, Clavelou P et al (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236\u20131242. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19306035","DOI":"10.1007\/s00415-009-5100-z"},{"key":"9799_CR33","doi-asserted-by":"crossref","unstructured":"Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Brain 118:707\u2013719. https:\/\/brain.oxfordjournals.org\/content\/brain\/118\/3\/707.full.pdf","DOI":"10.1093\/brain\/118.3.707"},{"key":"9799_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp-2015-311157","volume":"87","author":"MR Turner","year":"2016","unstructured":"Turner MR, Goldacre R, Talbot K, Goldacre MJ (2016) Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 87:244\u2013246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9799_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00415-013-7185-7","volume":"261","author":"A Rosenbohm","year":"2014","unstructured":"Rosenbohm A, Kassubek J, Weydt P et al (2014) Can lesions to the motor cortex induce amyotrophic lateral sclerosis? J Neurol 261:283\u2013290","journal-title":"J Neurol"},{"key":"9799_CR36","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3390\/ijms20143433","volume":"20","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Bhalerao A, Cucullo L (2019) Cerebrovascular and Neurological Disorders: Protective Role of NRF2. Int J Mol Sci 20:3433","journal-title":"Int J Mol Sci"},{"key":"9799_CR37","doi-asserted-by":"crossref","unstructured":"Kahl A, Blanco I, Jackman K et al (2018) Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci Rep 8:2701. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29426953","DOI":"10.1038\/s41598-018-21063-z"},{"key":"9799_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/ene.13620","volume":"25","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, Ferri L, Fasano A et al (2018) Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. Eur J Neurol 25:861\u2013868","journal-title":"Eur J Neurol"},{"key":"9799_CR39","first-page":"997","volume":"29","author":"E D\u2019Amico","year":"2013","unstructured":"D\u2019Amico E, Factir-Litvak P, Santella RM, Mitsumoto H (2013) Clinical perspective of oxidative stress in sporadic ALS. Free Radic Biol Med 29:997\u20131003","journal-title":"Free Radic Biol Med"},{"key":"9799_CR40","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1212\/WNL.0000000000002671","volume":"86","author":"E Roos","year":"2016","unstructured":"Roos E, Mariosa D, Ingre C et al (2016) Depression in amyotrophic lateral sclerosis. Neurology 86:2271\u20132277","journal-title":"Neurology"},{"key":"9799_CR41","first-page":"15","volume":"2015","author":"S K\u00f6rner","year":"2015","unstructured":"K\u00f6rner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S (2015) Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: Characterization of a large patient cohort. BMC Neurol 2015:15","journal-title":"BMC Neurol"},{"key":"9799_CR42","doi-asserted-by":"crossref","unstructured":"Lul\u00e9 D, H\u00e4cker S, Ludolph A, Birbaumer N, K\u00fcbler A (2008) Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int 105:397\u2013403. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19626161","DOI":"10.3238\/arztebl.2008.0397"},{"key":"9799_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/01.wnl.0000167187.14501.0c","volume":"65","author":"JG Rabkin","year":"2005","unstructured":"Rabkin JG, Albert SM, Del Bene ML et al (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65:62\u201367","journal-title":"Neurology"},{"key":"9799_CR44","doi-asserted-by":"crossref","unstructured":"Moore MJ, Moore PB, Shaw PJ (1998) Mood disturbances in motor neurone disease. J Neurol Sci 160(Suppl 1):S53\u2013S56. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9851650","DOI":"10.1016\/S0022-510X(98)00203-2"},{"key":"9799_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/21678421.2018.1530265","volume":"20","author":"A Verschueren","year":"2019","unstructured":"Verschueren A, Kianimehr G, Belingher C et al (2019) Wish to die and reasons for living among patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener 20:68\u201373","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"9799_CR46","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9562.1000423","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, McDonnell E, Schoenfeld D et al (2017) Functional decline is associated with hopelessness in amyotrophic lateral sclerosis (ALS). J Neurol Neurophysiol. https:\/\/doi.org\/10.4172\/2155-9562.1000423","journal-title":"J Neurol Neurophysiol"},{"key":"9799_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jns.2007.10.024","volume":"268","author":"CC Il","year":"2008","unstructured":"Il CC, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H (2008) Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci 268:40\u201347","journal-title":"J Neurol Sci"},{"key":"9799_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2004.06.024","volume":"1021","author":"GJ Groeneveld","year":"2004","unstructured":"Groeneveld GJ, Van Muiswinkel FL, Sturkenboom JM, Wokke JHJ, B\u00e4r PR, Van Den Berg LH (2004) Ovariectomy and 17\u03b2-estradiol modulate disease progression of a mouse model of ALS. Brain Res 1021:128\u2013131","journal-title":"Brain Res"},{"key":"9799_CR49","unstructured":"Heitzer M, Kaiser S, Kanagaratnam M et al (2017) Administration of 17\u03b2-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1(G93A) ALS mice. Mol Neurobiol 54:8429\u20138443. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27957680"},{"key":"9799_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"JH Veldink","year":"2018","unstructured":"Veldink JH, Sommer H, Weber M et al (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423\u2013433","journal-title":"Lancet Neurol"},{"key":"9799_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00415-018-8778-y","volume":"265","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, Malerba SA, Beghi E et al (2018) Riluzole and other prognostic factors in ALS: a population-based registry study in Italy. J Neurol 265:817\u2013827","journal-title":"J Neurol"},{"key":"9799_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/jnnp.2007.118018","volume":"79","author":"S Zoccolella","year":"2008","unstructured":"Zoccolella S, Beghi E, Palagano G et al (2008) Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 79:33\u201337","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09799-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:23:54Z","timestamp":1617751434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09799-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["9799"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09799-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}